Overview
VDRL detects reagin antibodies (anticardiolipin-type) that rise in syphilis and some biologic false-positive states; it is not treponeme-specific.
Clinical Importance
Syphilis screening or monitoring in selected protocols
CSF testing for neurosyphilis laboratory support
Specimen Requirements
- Specimen: serum (preferred for most serology/autoimmune immunoassays) or plasma when the method is validated
- Tube: gold/SST (serum separator) or red-top serum; follow method-specific plasma acceptability
- Handling: allow SST to clot fully; centrifuge and separate promptly; avoid repeated freeze–thaw
- Storage: refrigerate short-term; freeze aliquots for delayed testing per manufacturer stability
- Stability: analyte- and kit-specific; do not exceed validated time/temperature limits
- CSF: collect aseptically when neurosyphilis testing is ordered; follow institutional tube routing
Analytical Method
Heat-inactivated serum (classic method) is mixed with cardiolipin-lecithin-cholesterol antigen; flocculation is read microscopically. Quantitative dilutions yield titers. Reactive nontreponemal tests require treponemal confirmation.
Instruments Used
Automated analyzers
- Automated RPR analyzers (selected laboratories)
- Automated treponemal immunoassays (CLIA/ELISA) on major immunoassay platforms
- Roche Cobas immunoassay systems
- Abbott Alinity / Architect immunoassay systems
- Siemens Healthineers Atellica / ADVIA Centaur immunoassay systems
- Beckman Coulter Access / DxI immunoassay systems
Manual methods
- Manual RPR/VDRL flocculation cards
- Manual TPHA/TPPA and FTA-ABS fluorescence reading
Reference Values
Assay cutoffs, units, and reference intervals are method- and manufacturer-specific. Always interpret against the performing laboratory report (CLSI EP28-A3c for quantitative intervals where applicable). Serologic patterns require clinical correlation and current guideline algorithms (WHO/CDC/society guidance as adopted locally).
Nonreactive expected without syphilis or biologic false-positive conditions. Titers are reported as dilutions (e.g., 1:2, 1:4).
Interpretation
Common Causes of Increased Results
- Reactive VDRL; possible syphilis; confirm with treponemal test; titer used for follow-up
Common Causes of Decreased Results
- Nonreactive; does not exclude early/late syphilis; prozone phenomenon possible in high-titer disease
Clinical Significance
- Syphilis algorithms
- CSF nontreponemal testing
Factors Affecting Results
Pre-analytical
- Hemolysis, lipemia, or icterus (assay-dependent interference)
- Wrong tube type or incomplete clotting of SST
- Repeated freeze–thaw of serum aliquots
- Testing too early or too late relative to infection/vaccination timing for serology
Analytical
- Prozone false negatives without dilution
- Biologic false positives (autoimmune, pregnancy, other infections)
Post-analytical
- Reporting nontreponemal reactivity as confirmed syphilis without treponemal testing
Advantages and Limitations
Advantages
- Quantifiable titers for monitoring
- CSF application
Limitations
- Not treponeme-specific
- Manual method variability
Clinical Pearls
If clinical suspicion is high and VDRL is nonreactive, dilute for prozone; high titers can hide in plain sight.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods (verify current edition). Chapters on clinical immunology and serology.
- Rifai N, Horvath AR, Wittwer CT, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (verify current edition). Immunoassay and protein chapters.
CLSI and Professional Guidelines
- Centers for Disease Control and Prevention. Laboratory testing recommendations for infectious disease serology and related algorithms (verify current CDC guidance for the pathogen).
- Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory. CLSI document EP28-A3c (verify current edition).
- Clinical and Laboratory Standards Institute. Immunoassay and related method evaluation documents (e.g., EP05, EP06, EP07, EP17; verify current editions relevant to the assay).
- College of American Pathologists. Accreditation and proficiency testing expectations for immunology/serology (verify current CAP checklist requirements).
- International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Recommendations relevant to protein and immunoassay measurands (verify current IFCC documents).
WHO Publications
- World Health Organization. Laboratory and diagnostic guidance for serologic and immunologic testing (verify current WHO publication for the analyte/assay).
Frequently Asked Questions
Common questions about using this VDRL laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the VDRL laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of VDRL. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find VDRL specimen requirements?
See the Specimen Requirements section on this page for specimen information related to VDRL. Confirm collection details against your laboratory protocol.
Where are VDRL reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret VDRL results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for VDRL?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from VDRL?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading VDRL?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Immunology & Serology topic.
What are the clinical pearls for VDRL?
See the Clinical Pearls section for concise laboratory practice notes associated with VDRL. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.